Barry Moynihan - Concepedia

Author

Barry Moynihan

Also Known As

Anthony Pereira, B G Moynihan, B Moynihan, B. G. A. MOYNIHAN, B. Moynihan, Barry Moynihan, Cameron Dowling, David R. Hargroves, Margaret Large

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Beaumont Hospital Royal College of Surgeons in Ireland St George's, University of London Mater Misericordiae University Hospital University College Dublin

About

Barry Moynihan is an author at Beaumont Hospital specializing in medicine, neurology, and stroke.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	441
2	Health Sciences	2	2	129
3	Public Health	2	2	121
4	Cell Biology	2	2	103
5	Allergy	1	1	43

Barry Moynihan

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial Michael D. Hill, Mayank Goyal, Bijoy K. Menon, The Lancet	2020	601
Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial Martin Dennis, Gillian Mead, John Forbes, The Lancet	2018	276
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial Rustam Al‐Shahi Salman, M. J. S. Dennis, PAG Sandercock, The Lancet	2019	188
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial Philip M. Bath, Lisa J Woodhouse, Jason P. Appleton, The Lancet	2017	176
Using DTI to assess white matter microstructure in cerebral small vessel disease (SVD) in multicentre studies Iain D. Croall, Valerie Lohner, Barry Moynihan, Clinical Science Traumatic Brain InjuryWhite MatterMulticentre StudiesBrain LesionLongitudinal Neuroimaging	2017	103
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial Shelagh B. Coutts, Sandeep Ankolekar, Ramana Appireddy, The Lancet ThrombosisSuperiority TrialIschemic StrokeCardiovascular DiseaseMedicine	2024	101
Effect of Standard vs Intensive Blood Pressure Control on Cerebral Blood Flow in Small Vessel Disease Iain D. Croall, Daniel J. Tozer, Barry Moynihan, JAMA Neurology	2018	89
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial Rustam Al‐Shahi Salman, David Minks, Dipayan Mitra, The Lancet Neurology	2019	88
Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis Hugh S. Markus, Eric L. Harshfield, Annette Compter, The Lancet Neurology RadiologyEndovascular TechniqueCardiovascular DiseaseMedicineVascular Surgery	2019	66
Interleukin-6, C-reactive protein, fibrinogen, and risk of recurrence after ischaemic stroke: Systematic review and meta-analysis Éilis J. O’Reilly, Sarah Coveney, Rory Collins, European Stroke Journal	2021	63

Page 1